Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays

The SARS-CoV-2 pandemic has challenged molecular microbiology laboratories to quickly implement and validate diagnostic assays and to expand testing capacity in a short timeframe. Multiple molecular diagnostic methods received FDA emergency use authorization (EUA) and were promptly validated for use...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostafa, Heba H., Hardick, Justin, Morehead, Elizabeth, Miller, Jo-Anne, Gaydos, Charlotte A., Manabe, Yukari C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405824/
https://www.ncbi.nlm.nih.gov/pubmed/32777761
http://dx.doi.org/10.1016/j.jcv.2020.104578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405824/
https://www.ncbi.nlm.nih.gov/pubmed/32777761
http://dx.doi.org/10.1016/j.jcv.2020.104578

Ejemplares similares